Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
Clinical trial NCT02012634 · UNKNOWN
Trial details
- NCT number
- NCT02012634
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-12-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.